Cite Filings / ESLA / 9999999997-23-003622
Feed Companies Filings Check
Sign in
SEC STAFF LETTER

SEC Staff Letter Redacted Exhibit

Estrella Immunopharma, Inc. · Filed 2023-07-18 · Acc 9999999997-23-003622

Documents 1

  • SEC STAFF LETTER SEC Staff Letter Redacted Exhibit , filename1.pdf

Around this filing

  • 2023-07-21 8-K Material agreement · New debt or obligation · Unregistered share sale
  • 2023-07-19 425 Prospectus/Communication re Business Combination
  • 2023-07-19 8-K Material agreement · New debt or obligation · Unregistered share sale · Other events
  • 2023-07-19 8-K Material agreement · Bylaws or fiscal year change · Shareholder vote results · Other events
  • 2023-07-18 SEC STAFF LETTER SEC Staff Letter Redacted Exhibit
  • 2023-07-12 DEFA14A Proxy Materials
  • 2023-05-09 SEC STAFF LETTER SEC Staff Letter Redacted Exhibit

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading filename1.pdf…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…